Pleiotropic Effects of PCSK-9 Inhibitors

Basiak, M; Kosowski, M; Cyrnek, M; Buldak, L; Maliglowka, M; Machnik, G; Okopien, B

Kosowski, M (corresponding author), Med Univ Silesia, Dept Internal Med & Clin Pharmacol, Medykow 18, PL-40752 Katowice, Poland.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021; 22 (6):

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors are a group of drugs whose main mechanism of action is binding to the PCSK-9 molecul......

Full Text Link